• Pre Clinical And Clinical Research

BioIVT Enhances its Website to Facilitate Drug and Diagnostic R&D

BioIVT’s website now features advanced specimen search and e-commerce capabilities

Quell Therapeutics Significantly Expands Clinical Manufacturing Capacity for its Engineered Treg Cell Therapies through a Collaboration with the Cell and Gene Therapy Catapult

Collaboration to facilitate an expanded manufacturing footprint to enable clinical supply of Quell’s pipeline, including QEL-001 in liver transplantation and pipeline programs in neuroinflammation and autoimmunity.

BioIVT’s Biospecimen Repository and Clinical Database Prove Valuable Resources for AI-Enhanced Drug Discovery and Diagnostic Development

BioIVT’s ASTERAND® Human Tissue Repository contains clinical data from more than one million biospecimens and can be mined to reveal patterns and relationships in disease etiology and pathology.

Medannex leads the way in cancer charity fundraiser

A team of colleagues developing new cancer treatments has topped the charity fundraising leaderboard at the BioIndustry Association’s (BIA) ‘Research Relay’.

Selvita will develop a platform to produce focused libraries of bioactive compounds with the use of machine learning and AI methods

Krakow, Poland – September 06, 2021 – Selvita, one of the largest preclinical contract research organizations in Europe, announced today that it had received a grant funding of 1 M EUR to create a novel technological platform which will accelerate the drug discovery process. The grant came from the National Centre of Research and Development with a total of 1.7 M EUR dedicated to the project. The project will enable Company to implement new services for biotech and pharma clients.

Enesi Pharma appoints Elizabeth Eagling-Vose, MBA, as Senior Vice President, Operations

Experienced leader in clinical operations joins Enesi to drive the development of vaccine programmes enabled using its innovative ImplaVax® solid dose, needle free technology

Verona Pharma Presents Pharmacokinetic Data with Ensifentrine at the European Respiratory Society International Congress 2021

Results demonstrate co-administration of fluconazole has minimal effect on ensifentrine pharmacokinetics

Infex Therapeutics sharpens Covid focus with new CRUK Newcastle partnership

Infex Therapeutics is pressing ahead with a major development of its pandemic resilience strategy by today announcing an agreement with CRUK Newcastle Drug Discovery Unit.

SolasCure announces £15m Series A raise

Biotech start-up SolasCure has announced the completion of its Series A investment round, to support the development of their wound cleaning product, Aurase®.

IONTAS collaboration with F-star enters oncology Phase 1 clinical trial

Cambridge, UK,– 29 June 2021: IONTAS Limited (IONTAS), a leader in the discovery and optimization of fully human antibodies, today announces that F-star Therapeutics, Inc. (NASDAQ: FSTX), has dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody.